logo
Share SHARE
FONT-SIZE Plus   Neg

Anacor Pharma Says GSK Voluntarily Paused Enrollment Of Ongoing GSK '052 Trials

Anacor Pharmaceuticals Inc (ANAC) Monday announced that its partner GlaxoSmithKline (GSK) has voluntarily paused enrollment in its current clinical trials of GSK2251052.

Anacor further stated that GSK had recently identified microbiological finding in a small number of patients in the Phase 2b trial of GSK '052 for the treatment of complicated urinary tract infections.

GSK is in the process of obtaining additional information in order to better understand the data, but will not resume the trials until it has concluded its investigation. Upon completion of the review, GSK will determine next steps regarding the future development of GSK '052.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Uncertainty has become the name of the game, as the new president is set to assume office. Groundwork is being done for major policy overhauls, with the first step towards repealing the Obamacare taken, as Senators voted 51-48 to approve a budget resolution for achieving the same. The House is set to... A country's productivity is measured by dividing its gross domestic product or GDP in U.S. dollars and normalized to purchasing power parities by the total number of hours worked by the country's workforce in a year. It is considered as a key driver of long-term economic growth and living standards. CLICK... Millennials are earning 20 percent less than their parents did and have accumulated only half the assets than their baby boomer parents, new research showed. According to an analysis of Federal Reserve data by the advocacy group Young Invincibles, baby boomers were much more financially secure than millennials when they were the same age.
comments powered by Disqus
Follow RTT